S-1 · primary offering
Issued 2023
Proposed maximum
Shares registered
- Filed
- Effective
IBO$4.15+3.49%
Impact Biomedical Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: NYSE
Mkt Cap:$35.46M
Float & O/S:
Inst Own:
DilutionScan read 17 of IMPACT BIOMEDICAL INC.'s SEC filings and found 1 warrant series, 2 convertibles, 1 S-1 registration and 1 completed offering on file for IBO. The latest dilution event on file is an offering on Oct 16, 2025. Analysis updated Oct 9, 2026.
Signal8 Summary
Raise routes on file: no active ATM, effective shelf, S-1 or equity line in the filings read · latest dilution event 383 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Oct 16, 2025 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Completed
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Series A Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Offering
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your IBO trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
